Letters to the Editor

Planned withdrawal of dexamethasone after pomalidomide low dose dexamethasone induction for lenalidomide refractory multiple myeloma (ALLG MM14)

Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital‐Monash University, Melbourne, Victoria, Australia; Department of Clinical Haematology, Monash University, Clayton, Victoria
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital‐Monash University, Melbourne, Victoria
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital‐Monash University, Melbourne, Victoria
Royal Prince Alfred Hospital, Sydney
Princess Alexandra Hospital and University of Queensland, Brisbane
The Canberra Hospital, Canberra
Icon Cancer Centre, Brisbane
Concord Repatriation General Hospital, University of Sydney, Sydney
Nanix Ltd., Dunedin, New Zealand; Department of Microbiology and Immunology, University of Otago
Department of Microbiology and Immunology, University of Otago
Materials Characterisation and Fabrication Platform, Department of Chemical Engineering, University of Melbourne
Department of Epidemiology and Preventive Medicine, Alfred Health – Monash University, Melbourne, Victoria
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria
Faculty of Medicine, University of Melbourne, St Vincent’s Hospital Melbourne, Australia [on behalf of The Australasian Leukaemia and Lymphoma Group (ALLG)]
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital‐Monash University, Melbourne, Victoria, Australia; Department of Clinical Haematology, Monash University, Clayton, Victoria
Haematologica Early view Sep 30, 2021 https://doi.org/10.3324/haematol.2021.278655